Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Orthofix Medical Inc. OFIX
$18.03
-$0.29 (-1.61%)
На 18:00, 12 мая 2023
+71.94%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
659117248.00000000
-
week52high
29.10
-
week52low
13.76
-
Revenue
460713000
-
P/E TTM
-19
-
Beta
0.86332100
-
EPS
-0.95000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stifel | Buy | Hold | 04 мар 2022 г. |
| Stifel | Hold | 25 ноя 2020 г. | |
| Sidoti & Co. | Buy | Buy | 25 ноя 2020 г. |
| Cantor Fitzgerald | Neutral | Neutral | 25 ноя 2020 г. |
| Stifel | Hold | 20 окт 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Kenny Kevin J. | D | 143231 | 2287 | 01 февр 2023 г. |
| Serbousek Jon Carl | D | 352968 | 5142 | 01 февр 2023 г. |
| Elting Kimberley A. | D | 183164 | 2015 | 01 февр 2023 г. |
| Keran Patrick L | D | 88199 | 999 | 30 янв 2023 г. |
| Bostjancic John J. | D | 103453 | 1694 | 30 янв 2023 г. |
| Valentine Keith | D | 394031 | 5824 | 30 янв 2023 г. |
| Serbousek Jon Carl | A | 358110 | 81967 | 05 янв 2023 г. |
| Serbousek Jon Carl | A | 276143 | 40764 | 05 янв 2023 г. |
| Serbousek Jon Carl | A | 235379 | 45872 | 05 янв 2023 г. |
| Kenny Kevin J. | A | 146350 | 832 | 05 янв 2023 г. |
Новостная лента
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 18:20
Orthofix (OFIX) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.10 per share a year ago.
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023
Business Wire
26 апр 2023 г. в 16:01
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2023 financial results on Tuesday, May 9, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the even.
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Dips
Zacks Investment Research
10 мар 2023 г. в 09:57
Orthofix (OFIX) reports impressive performance across the BGT and Global Orthopedics segment in the fourth quarter.
Orthofix Medical, Inc. (OFIX) Q4 2022 Earnings Call Transcript
Seeking Alpha
06 мар 2023 г. в 19:10
Orthofix Medical Inc. (NASDAQ:OFIX ) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET Company Participants Alexa Huerta - Senior Director, Investor Relations Keith Valentine - President and Chief Executive Officer John Bostjancic - Chief Financial Officer Jon Serbousek - Director, Executive Chairman of the Board Doug Rice - Former Chief Financial Officer Conference Call Participants Mathew Blackman - Stifel Jeffrey Cohen - Ladenburg Thalmann Dave Turkaly - JMP Securities Operator Good afternoon and welcome to Orthofix Medical's Q4 and Full-Year 2022 Earnings Call. All participants are in a listen-only mode.
Orthofix Medical, Inc. (OFIX) Q3 2022 Earnings Call Transcript
Seeking Alpha
05 ноя 2022 г. в 22:42
Orthofix Medical, Inc. (NASDAQ:OFIX ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Alexa Huerta - Senior Director, IR Jon Serbousek - President, CEO & Director Douglas Rice - CFO & CAO Conference Call Participants David Turkaly - JMP Securities Mathew Blackman - Stifel, Nicolaus & Company Jeffrey Cohen - Ladenburg Thalmann & Co. James Sidoti - Sidoti & Company Operator Good morning. My name is Gavin and I will be your conference operator today.